Litigation (4)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bombay High Court disposes of Writ Petition No. 5671 of 2026 filed by Md. Abubakar against SEBI as withdrawn, with liberty to pursue … | |||||||||||||||
Bombay High Court disposes of Writ Petition No. 5671 of 2026 filed by Md. Abubakar against SEBI as withdrawn, with liberty to pursue appellate remedy before the Supreme Court under Section 15Z of the SEBI Act, 1992.
| |||||||||||||||
NATCO Pharma provides clarification on ongoing litigation news, while Cipla addresses USFDA Form 483 inspectional observations at supply … | |||||||||||||||
NATCO Pharma provides clarification on ongoing litigation news, while Cipla addresses USFDA Form 483 inspectional observations at supply partner Pharmathen's Greece facility.
| |||||||||||||||
NATCO Pharma clarifies ongoing litigation with no current material impact, while Cipla addresses USFDA Form 483 observations at partner … | |||||||||||||||
NATCO Pharma clarifies ongoing litigation with no current material impact, while Cipla addresses USFDA Form 483 observations at partner facility Pharmathen manufacturing Lanreotide Injection.
| |||||||||||||||
Vodafone Idea provides clarification on news article regarding Supreme Court order on AGR dues. Supreme Court allows Union of India to … | |||||||||||||||
Vodafone Idea provides clarification on news article regarding Supreme Court order on AGR dues. Supreme Court allows Union of India to reconsider AGR matter given government's 49% equity stake and public interest involving 20 crore customers.
| |||||||||||||||